SCB-2019 as COVID-19 Vaccine
Clinical trial NCT04405908 · COMPLETED
Trial details
- NCT number
- NCT04405908
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2021-10-20
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.